In Vitro Activity of the New Oxazolidinone AZD2563 against Enterococci

The activity of a new oxazolidinone antimicrobial, AZD2563, was assessed against >500 clinical isolates of enterococci representing six species. All isolates, including those resistant to other antibiotic classes, were inhibited by AZD2563 at concentrations ≤2 μg/ml, except for four strains resistan...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Eliopoulos, G. M., Wennersten, C. B., Moellering Jr., R. C.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC128778/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12234858/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.10.3273-3275.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!